Lung-MAP master protocol model broadens trial

As compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cancer Master Protocol (Lung-MAP) has enrolled higher percentages of patients who are older, patients who are from rural or socioeconomically deprived areas, and patients who have Medicaid or no insurance.

Related Keywords

Oregon ,United States ,Staceyj Adam ,Karen Kelly ,Michaell Leblanc ,Roys Herbst ,Riha Vaidya ,Ellenv Sigal ,Jhanellee Gray ,Maryw Redman ,Katherine Minichiello ,Davidr Gandara ,Martinj Edelman ,Josephm Unger ,Lu Qian ,Shakun Malik ,Konstantinh Dragnev ,Joelw Neal ,Jyotid Patel ,Saiaman Waqar ,Charlesd Blanke ,Foundation Medicine ,Dartmouth Cancer Center ,Uc Davis Comprehensive Cancer Center ,Emory University ,Science University ,Amgen ,Bristol Myers Squibb ,Community Oncology Research Program ,Genentech ,Astrazeneca ,Twitter ,Yale Cancer Center ,National Clinical Trials Network ,National Cancer Institute Clinical Trials Network ,National Institutes Of Health ,Foundation For The National Institutes Of Health ,Moffitt Cancer Center ,Washington University School Of Medicine ,Pfizer ,Stanford Cancer Institute ,Fred Hutchinson Cancer Center ,Cancer Research Network ,Northwestern University Feinberg School Of Medicine ,Fox Chase Cancer Center ,Winship Cancer Institute ,Oregon Health ,Friends Of Cancer Research ,Method Of Research ,Temple University Health System ,National Cancer Institute ,Data Management Center ,Lung Cancer Master Protocol ,National Clinical Trials ,National Institutes ,Research Network ,Cancer Research ,Area Deprivation Index ,Comprehensive Cancer Center ,Northwestern University Feinberg School ,Washington University School ,Fred Hutchinson Cancer ,Patients Enrolled ,Oncology Research Program ,